Previously, it was demonstrated that the induction and overexpression of the tumor suppressor gene TP53 (p53) prevent cancer-specific aberrant splicing of TSG101 pre-mRNA [10,15], i.e., generation of the re-spliced TSG101Δ154-1054 mRNA [9]. The gene discussed is TP53; the disease is cancer.